Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-21

FDA Approved: CABENUVA — Original Application (ViiV Healthcare Company)

View source ↗

Summary

The FDA approved CABENUVA (cabotegravir and rilpivirine) as the original approval for a long-acting injectable regimen to treat HIV-1 infection in adults who ar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CABENUVA (cabotegravir and rilpivirine)

Snippet

ORIG AP for CABENUVA (CABOTEGRAVIR AND RILPIVIRINE)